Skip to main content
Clinical Trials/CTRI/2024/12/077969
CTRI/2024/12/077969Not yet recruitingNot Applicable

Quality of life after penile cancer surgery

KMC, Manipal1 site in 1 country56 target enrollmentStarted: January 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
56
Locations
1
Primary Endpoint
Health related Quality of Life

Study Overview

Brief Summary

Penile cancer surgery, often described as mutilating, profoundly impacts patients’ well-being, psycho-socio health, and social relationships. By analyzing patient records and utilizing standardized assessments, the study seeks to provide insights into the post treatment quality of life and sexual function. This can help in preoperative counselling, informed decision making and tailoring surgical approaches to optimize outcomes for individuals undergoing penile cancer surgery.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • All patients who underwent surgical treatment of penile cancer in the last 5 years.

Exclusion Criteria

  • distant metastasis, recurrent penile cancer, second primary tumour and if not willing to participate in the study.

Outcomes

Primary Outcomes

Health related Quality of Life

Time Frame: 1 year

Secondary Outcomes

  • Sexual Quality of Life(1 year)

Investigators

Sponsor
KMC, Manipal
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Siddalingeshwara Chandragowda Doddamani

Kasturba Medical College Manipal

Study Sites (1)

Loading locations...

Similar Trials